The first total syntheses of the title fungal metabolites preussomerins F, K and L are described and their structures confirmed thereby. The syntheses were achieved following a versatile, unified non-biomimetic approach, which is easily extendable to prepare other known and novel members of this family. Key steps include the functionalisation of a 2-arylacetal anion, tandem one-pot Friedel-Crafts cyclisation-deprotection, regioselective substrate-directable hydrogenation and reductive opening of epoxides.
Introduction
In the last two decades, an extensive number of novel bis-naphthalene-based bioactive natural products have been isolated from fungi. 1 Biosynthetically, all these metabolites have a common origin, being generated by radical oxidative dimerisation of two naphthalene units via the 1,8-dihydroxynaphthalene (DHN) pathway.
2 These growing new families of spirobisnaphthalene natural products have a unique structural feature involving two or three oxygen atoms acting as bridges connecting the original naphthalene subunits, which additionally exhibit an elaborate range of functionality patterns, generally involving partial saturation and further oxidation of the original aromatic cores.
Most of these metabolites exhibit significant antifungal and antibacterial properties as a consequence of the interspecies competition among dung-inhabiting fungi in nature. However, the main biological interest concerns their capability to inhibit farnesyl-protein transferase (FTPase) in a highly selective fashion. This enzyme plays a critical role in the post-translational modification of a huge range of different proteins involved in intracellular signalling. 3 In particular, FTPase attaches a farnesyl group to the thiol of a cysteine side chain of the Ras proteins. The cysteine residue belongs to a characteristic carboxy-terminal consensus sequence known as the CAAX box, whose prenylation is of great importance in cellular proliferation through membrane-binding processes. One of the substrates of the FTPase is the protein GTPase Ras, whose oncologically mutated form is found in over 30% of human cancers, particularly colon, lung, thyroid, bladder and pancreatic carcinomas, as well as in several types of leukaemias. As a result, FTPase inhibitors have been developed as potential antitumour therapeutic drugs, blocking the growth of human cancers. 4 Recent studies have demonstrated that these compounds also constitute an efficient alternative therapy for the treatment of parasitic infections, especially against malaria. 5 These achievements have been mainly based on screening of natural products. Among the main representative groups of spirobisnaphthalene-derived naturally occurring substances with FTPase inhibitory activity are the diepoxins, 6 palmarumycins, 7 spiroxins 8 and preussomerins. Figure 1 illustrates a representative example of each family.
This paper is concerned with the preussomerin family of natural products, which currently consists of 13 known fungal metabolites (Figure 2) . 9 Preussomerin A was the first member of the family to be isolated from the coprophilous fungus Preussia isomera by Gloer and co-workers in 1990. 9a Subsequently, closely related preussomerins B-F were isolated from the same organism. 9b Preussomerin D was also later isolated from the endophytic fungus Hormonema dematioides recovered from living plant tissue of a coniferous tree. New additions to this family of natural products came in 1994, when Singh and co-workers isolated preussomerins G, H, and I from an unidentified dung-inhabiting coelomycetous fungus (MF5916). 9d An unusual new preussomerin analogue, characterised as 3'-Odesmethyl-1-epi-preussomerin C, was next isolated from cultures of the coprophilous fungus Sporormiella vexans. 9e Most recently, the latest additions to the family were reported by Krohn and co-workers, who isolated three new representatives, preussomerin J, K and L from a non-taxonomically characterised endophytic fungi (Mycelia sterila) from the roots of Atropa belladonna, confirming their absolute configuration by elegant comparison of experimental and theoretical CD spectra. 9f Preussomerin K, as well as preussomerins E-I, were also isolated independently by Isaka and co-workers from a lichenicolous fungus Microsphaeropsis sp. BCC 3050. 9g These authors have suggested that preussomerin I could be a by-product generated during the isolation protocol by Michael addition of MeOH to preussomerin G, while preussomerins J and K look to be real metabolites present in the crude strain extract before purification. The interest of our own group in preussomerins began as part of a program to prepare a range of different FTPase inhibitors for biological screening (e.g. manumycin A, 12 palmarumycins CP 1 , CP 2 , and C 11 , CJ-12371 and deoxypreussomerin A 13 ). Our approach is based on a novel non-biomimetic strategy involving the use of 2-arylacetal anions obtained from a simplified bis-acetal (Scheme 1b).
The proposed synthetic pathway described herein involves the formation of the bis-ketal in a single step and at an early stage of the synthesis, with subsequent elaboration of the outer fringes of the molecule. We initially investigated the use of this methodology for the construction of advanced synthetic preussomerin analogues containing the full carbon skeleton of the natural products 14 and subsequently we applied these methods in the total syntheses of preussomerin K and L. 15 Now, in this paper, we describe full details of our optimised and extended approach towards the total syntheses of preussomerins K and L as well as reporting the first synthesis of preussomerin F.
Results and discussion
Our approach is novel in that the bis-acetal nucleus of the preussomerins is formed at the start of the synthesis. Thus, the inexpensive and readily available 4-methoxyphenol was converted into multigram quantities of 5-methoxysalicylaldehyde 2 by an easy, magnesium methoxide-mediated ortho-specific formylation in good yield (>90% in a 30 g scale). 16 Subsequent dimerisation of 2 smoothly provided the key racemic bis-acetal 3 in excellent yield following our previously described methodology (Scheme 2).
14 A simplification of this earlier procedure allowed us to isolate 3 without extractive work-up by direct filtration and washing with petrol, avoiding the large scale recrystallisation from diethyl ether previously employed. We were then in a position to elaborate 3 into the full preussomerin skeleton.
Acetal protons from the key intermediate 3 were predicted to be acidic due to donation of the resulting negative charge into the adjacent * anti-bonding orbitals, thus allowing sequential alkylation of the 2 and 2′-positions. Construction of the saturated rings A and D of the preussomerin skeleton should then be possible by further elaboration of newly introduced alkyl groups.
We needed to introduce a functionalised alkyl group, which would allow us to subsequently elaborate the A and D rings of preussomerins. We chose first to utilise the allyl group. From the practical point of view, model studies demonstrated that the first deprotonation of the bis-acetal 3 could be achieved with n-BuLi. This carbanion was allylated easily in high yield. However, the second 10, 11 and via a bis-acetal intermediate. 14 deprotonation was found to be more complex, and required the use of a stronger base. s-BuLi gave a significant improvement for this second deprotonation, allowing the introduction of a second allyl group. The sequential deprotonation-alkylation of intermediate 3 allowed us to introduce a double allyl functionality giving 4, which was further converted into the bis-primary alcohol 5 using 9-BBN followed by oxidative work up (Scheme 3).
Despite the success of the conversion of 4 into 5, we found that this procedure was practically difficult and gave variable yields. A higher yielding and more direct way of accessing diol 5 involving a one-pot deprotonation-alkylation sequence using oxetane as the electrophile was thus developed. The first alkylation proceeded smoothly using n-BuLi as base giving 6. The second alkylation used sBuLi as base. This latter alkylation must be carried out in the presence of a Lewis acid, such as BF 3 ·etherate, to allow reasonable yields.
The reaction was further improved by adding the oxetane-BF 3 ·etherate system sequentially at low temperature (-100 ºC) and by using an excess of the electrophile for the second alkylation (Scheme 3). Under these conditions, the symmetrical diol 5 was provided in a moderate 52% overall yield, along with monoalcohol 6 (32% yield).
Our next step was to convert diol 5 into its diacid derivative 7 with the aim of then carrying out a double Friedel-Crafts acylation on to the neighbouring aromatic cores, constructing the new rings A and D simultaneously. Oxidation of diol 5 was achieved by two procedures. We initially oxidised 5 using the Swern oxidation, giving the corresponding intermediate dialdehyde, which in a second step was oxidised further to the required diacid 7. The second oxidation was conducted using silver oxide, generated in situ from silver nitrate and potassium hydroxide (Scheme 4). However, an optimised transformation was achieved by direct Jones oxidation, which provided the diacid 7 in higher yields (95%) and shorter time and for a fraction of the cost.
After activating the diacid 7 in situ as the acid chloride, treatment with a homogenous solution of AlCl 3 in nitromethane at room temperature produced the Friedel-Crafts adduct 8 in good yield (75%) after 30 minutes. However, if the reaction was allowed to stand for longer time in the presence of an excess of AlCl 3 , two new compounds, characterised as 9 and 10, began to appear, indicating that ii) H H Scheme 3 Sequential functionalisation of the bis-acetal core. Reagents and conditions: i) a) n-BuLi, THF, -78 ºC; b) Allyl bromide; c) s-Buli, THF, -78 ºC; d) Allyl bromide, (52%); ii) a) 9-BBN, THF, 0º C; b) NaOH, H2O2 (62%). One-pot procedure. Reagents and conditions: iii) nBuLi, THF, -78 ºC, 30 min; then oxetane, BF3.Et2O, from -100 to -40 ºC over 90 min; then s-BuLi, THF, -78 ºC, 30 min; then oxetane, BF3.Et2O, from -100 to -40 ºC over 4 h, (52% 5, 32% 6). Scheme 5 Reagents and conditions: i) a) (COCl)2, DMF (cat), dichloromethane, 0 ºC to rt, 1 h; b) AlCl3, MeNO2, dichloromethane, 20 h, then 20% aq. Rochelle's salt (10% 8; 44% 9; 33% 10).
after a rapid cyclisation (less than 1 hour to completion), the remaining Lewis acid slowly carried out the cleavage of the phenolic methoxy groups (Scheme 5). Compounds 8-10 all contain the full preussomerin hydrocarbon skeleton but, additionally, in compound 9 the symmetry has been broken. Thus, in a one-pot fashion both the critical intramolecular cyclisation as well as the monodeprotection of one the phenolic moieties has been achieved. The reaction has proved to be easily scalable to provide a 44% yield of compound 9. Both by-products 8 and 10 are easily separable from 9 and can be recycled to improve the overall yield. We next investigated the deoxygenation of the free phenol group on intermediate 9. This transformation was accomplished by an initial activation of the phenol group as the triflate 11, which was removed by hydrogenation using Pearlman's catalyst to provide 12 in good overall yield (Scheme 6).
Having established an easily scalable route to 12, our attention became focused on its conversion into dienone 15. Early investigations regarding the direct dehydrogenation were unsuccessful (e.g. benzeneseleninic anhydride, 13 DDQ, etc.). When we applied the IBXmediated direct dehydrogenation method recently described by Nicolaou and co-workers, 17 we found the monounsaturated compound 13 was the main product, while most of the starting material remained unreacted (or was finally degraded if reaction conditions were forcing or the time prolonged) (Scheme 6).
This problem was circumvented by preparation of the disilyl enol ether 14, which was converted into dienone 15 (Scheme 6). We again investigated the use of the IBX-MPO complex, 18 which generated the dienone 16, but only in moderate 41% yield (plus 20% recovered 12). However, the same transformation could be accomplished efficiently under the classical conditions of the Saegusa reaction, 19 yielding dienone 15 in 91% yield using super-stoichiometric Pd(OAc) 2 (2.2 equiv.). Catalytic conditions were unsuccessful for this reaction. 20 At this stage, we focused our attention on preussomerins K and L. The special structural features of these molecules (Subtype II targets) lie in the characteristic -hydroxyketone moiety. Two approaches were examined to install this moiety. We first investigated the conjugate addition of oxygenated nucleophiles onto the enone systems (Scheme 7).
Conjugate addition of methanol was achieved cleanly converting 15 into its -methoxy adduct 16. 10 It must be noted at this point that the conjugate addition of the oxygenated nucleophiles proceeded with complete stereoselectivity on the less hindered faces of the dienone 15. The strong steric hindrance provided by the -(O3)oxygen makes the top face of the preussomerin core inaccessible to nucleophiles due to the unique spatial disposition of the two planar subunits of the molecule, which are almost perpendicular to each other.
Unfortunately, demethylation of the adduct 16 resulted in extensive degradation of the starting material due to the remarkable resistance of the -methoxy group to cleavage under all conditions attempted. For this reason, we investigated the epoxidation of dienone 15. This
Scheme 6 Reagents and conditions: i) Tf2O, pyridine, dichloromethane, -10 ºC to rt; ii) H2, 20% Pd(OH)2/C, Et3N, MeOH/EtOAc (3:1) v/v, (82%, two steps); iii) TMSOTf, 2,6-lutidine, 0 ºC to rt, 1 h; iv) Pd(OAc)2 (2.2 equiv), CH3CN, rt, 16 h (91%, two steps). v) IBX-MPO (3 equiv), DMSO, rt, 90 min (41%) (61% based on recovered 12); vi) IBX, toluene, DMSO, 80 ºC, 3 d (10%).
was successfully carried out using excess tert-butyl hydroperoxide (TBHP) in presence of the guanidine base 1,3,4,6,7,8-hexahydro-2H-pyrimido[1,2-a]pyrimidine (TBD) following our own methodology 21 to yield the bis-,-epoxyketone 17 in excellent yield with total stereoselectivity. In the subsequent step, ring-opening of the diepoxide using a selenium-mediated process 22 proved straightforward and the bis--hydroxyketone 18 could be obtained in good yield by a regio-and stereoselective transformation. Removal of the methyl ether group on the phenolic oxygen in 18 was achieved successfully under very mild conditions using 9-I-BBN 23 affording the first of the natural products, preussomerin L.
The structural identities of 17 and 18 were confirmed by X-ray crystallographic analysis. The ORTEP 24 representations are shown in Figure 3 . 25 It should be noted that both structures are exactly in accordance with those reported for the natural products (with the two aromatic rings almost perpendicular to each other). The epoxide pathway was also used to access preussomerin K. We anticipated that the ,-epoxyketones from each subunit of the intermediate 17 would have different reactivity. The presence of an electron-donating methoxy group on the northern hemisphere of the molecule influences the electronic behaviour of the vicinal carbonyl group, making it less electron-deficient than the carbonyl in the southern hemisphere of the molecule. We therefore treated 17 with a sub-stoichiometric amount of organoselenide and, as predicted, reduction of diepoxide 17 generated predominantly compound 19 (54%). The monoepoxide 20 and recovered 17 could be recycled to afford additional amounts of diol 18 (needed for preussomerin L synthesis).
Attempts to demethylate 19 (9-I-BBN, bromocatechol borane, etc.) resulted in extensive degradation of the extremely sensitive epoxide moiety. We circumvented this limitation by using excess boron tribromide, which provided the intermediate bromohydrin 21. The epoxide was then regenerated by basic treatment of 21 affording preussomerin K (Scheme 7).
The data from the synthetic samples of preussomerin K and L matched with those obtained by analysing authentic samples of the natural compounds kindly provided by Prof. K. Krohn. Table 1 shows the 13 C NMR shifts found from synthetic preussomerin K and those reported for the natural product.
Scheme 7 Reagents and conditions: i) LiOMe, MeOH, rt, 5 min (quantitative); ii) TBHP, TBD, toluene, 0 ºC to rt, 1 h (90%); iii) (PhSe)2 (2.5 equiv), NaBH4, EtOH, 0 ºC to rt, 1 h (67%); iv) 9-I-BBN, dichloromethane, 0 ºC to rt, 1 h (42%) (69% based on recovered 18); v) (PhSe)2 (0.9 equiv), NaBH4, EtOH, AcOH, 0 ºC to rt, 1h, (54% 19); vi) BBr3 (4 equiv), dichloromethane, -78 ºC to rt, 1 h; vii) LiOMe, t-BuOH, rt, 10 min (50%, plus 17% preussomerin L).
Figure 3 ORTEP drawing of compound 17 and 18 (50% probability thermal ellipsoids).
Next, we wished to extend this methodology to access Subtype III preussomerins. This required the regioselective reduction of the carbonyl on the southern hemisphere of the molecule. In our case, we found the catalytic hydrogenation was the key method for a simple and practical solution to this problem. During the deoxygenation of triflate 11, we found that a new more polar compound began to appear after prolonged reaction times (>24 h). This compound was characterised as 22 (Scheme 8). Over-reduction occurred in a regioselective fashion at the southern carbonyl group. This serendipitous finding allowed us to access a new key intermediate from which we were able to synthesise a Subtype III preussomerin.
We therefore concentrated our attention on the development of the optimal conditions for the efficient conversion of 11 into 22. The original conditions (Pearlman's catalyst) were very slow. Only extended reaction times (>5 d) allowed 22 to be obtained in moderate yield. We therefore screened different catalysts, finding that 5% Pd on activated charcoal produced an efficient over-reduction and generated 22 in 50% yield after 20 hours. Another product of over-reduction was found to be formed under these conditions, being characterised as the diol 23. Its amount increased as the reaction time was extended, but by limiting the reaction time to 20 hours less than 10 % was obtained (See Scheme 8).
This transformation is quite versatile in terms of reuse of the over-reduced products. Compound 23 can be straightforwardly oxidised to form 12 by Jones oxidation and 12 can be hydrogenated to give 22 with Et 3 N/MeOH/EtOAc as solvent. However, hydrogenation of 12 under standard conditions afforded an unexpected result. In the absence of triethylamine, the rapid deoxygenation of both carbonyls occurred, affording 24 in quantitative yield (Scheme 8). The use of triethylamine as co-solvent allowed controlled reduction, giving 22 in 50% yield (8-12 h ). The role of triethylamine still remains unclear, but is probably related to a poisoning effect on the catalyst.
With the key intermediate 22 in hand, we embarked on a synthesis of preussomerin F. The approaches followed are shown in Scheme 9. First protection of the benzylic hydroxyl group was carried out to preclude any risk of elimination during the subsequent reactions. Protection as the MOM derivative proceeded smoothly affording 25a in high yield. 
iv)
The next step involved generation of the enone. Taking advantage of our previous experience in this field, we attempted the Saegusa reaction via the silyl enol ether derived from 25a. Surprisingly, the mild method used before (TMSOTf, 2,6-lutidine) failed when it was applied to 25a. The best results were obtained using sodium hexamethyldisilazane in THF (1.1 equiv.) at -40 ºC, trapping the enolate in situ with excess TMSCl. The intermediate silyl enol ether proved to be extremely sensitive. Removal of the solvent without work-up, redissolving the crude product in acetonitrile and treatment with Pd(OAc) 2 without additional purification gave enone 26a in 54% yield with 25a being recovered in 25% yield (this could be recycled increasing the overall yield). Epoxidation of enone 26a proceeded efficiently using the guanidine base-mediated epoxidation affording 27a in high yield.
The structure of 27a was confirmed by X-ray crystallographic analysis. The ORTEP 24 representation is shown in Figure 4 . 26 As in the previous series, the two quasi-planar subunits are almost perpendicular to each other.
Deprotection of the MOM group in 27a proceeded smoothly under mild conditions providing 9-O-methoxy preussomerin F (28). Removal of the methoxy protecting group of 28 was attempted using the same strategy described earlier via the intermediate bromohydrin and subsequent epoxide regeneration with base. Unfortunately, treatment of 28 with boron tribromide produced extensive degradation of the epoxide without formation of the desired bromohydrin. No method employed gave clean demethylation of the phenol without degrading the epoxide.
We therefore turned our attention to a modified route in which the methyl ether protecting group was removed prior to the generation of the epoxide.
Demethylation was carried out on 25a using lithium iodide in refluxing pyridine, affording 25b in 93% yield. The Saegusa reaction was repeated with this substrate producing enone 26b in 68% yield. Unfortunately, epoxidation failed on this substrate despite extensive experimentation. We therefore realised the need to protecting the phenol group for the epoxidation. We for that reason introduced on 25b a second MOM group converting it cleanly into 25c (85%). Saegusa reaction on 25c allowed the preparation of enone 26c and epoxidation now efficiently afforded 27c. The final acid-catalysed deprotection of MOM groups in 27c proved to be troublesome due to the high lability of epoxide. While the phenol-protecting MOM is easily and rapidly removed, the benzylic MOM removal requires heating and longer reaction times to be completed, thus damaging the sensitive epoxide. However, after extensive experimentation, we were able to develop optimised conditions, which afforded preussomerin F in good yield (66%) with diol 29 as the only by-product in 34% yield (Scheme 9). 
Conclusion
In summary, we have successfully synthesised the racemic natural products preussomerin F (3% overall yield, 13 steps) and preussomerins K and L (4% overall yields in both cases, 11 and 10 steps, respectively) from very simple, inexpensive and easily available starting materials through the application of a straightforward non-biomimetic strategy with the functionalisation of 2-arylacetal anions, simultaneous one-pot Friedel-Crafts cyclisation-deprotection and substrate-regiocontrolled hydrogenation as the key steps of the syntheses. The above methodology is extremely versatile and could be used for the preparation of a range of preussomerin analogues by simple functional group interconversion. Further studies to develop asymmetric approaches to enantiomerically pure compounds are currently under investigation and will be reported in due course.
Experimental General Information
All reactions were carried out in oven-dried glassware under an inert atmosphere (argon or nitrogen) unless stated otherwise. All solvents were freshly distilled prior to use when anhydrous conditions were required. THF was distilled from sodium/benzophenone, and acetonitrile, dichloromethane, methanol, ethanol and toluene from CaH 2 . Chemicals were purchased from commercial suppliers and were used as received without further purification. Analytical thin-layer chromatography (TLC) was performed on precoated aluminium silica gel plates (Merck 60F254, 0.25 mm). Product spots were visualised under UV light (lamp at 254 or 360 nm), or dipped into any of the following solutions: phosphomolybdic acid (PMA), 2,4-dinitrophenylhydrazine (DNP) or vanillin, followed by heating with a hot gun. Flash column chromatography was performed on silica gel (Merck, 230-400 mesh). Melting points were measured on an electrothermal IA9100 digital melting point apparatus and are uncorrected. Infrared (IR) spectra were recorded on an ATI Mattson Genesis FT-IR spectrometer; deposited samples were prepared by dissolving solids in a small volume of CHCl 3 and forming a thin film on a NaCl plate by allowing the solvent to evaporate. 1 H and 13 C NMR spectra were taken at room temperature . J values are given in Hz. Carbon and proton assignments were based on 13 C-1 H Heteronuclear Singlet Quantum Correlation (HSQC), Heteronuclear Multiple Quantum Correlation (HMQC) and gradient-COSY experiments including large range correlation experiments (HMBC). Stereochemical configuration of key intermediates was determined by selective nOe irradiation of the selected peaks. Low resolution electron impact mass spectra were recorded on a Kratos MS 25 spectrometer. Both low and accurate mass with CI and FAB techniques were carried out on a Micromass Autospec spectrometer. The following abbreviations were used for solvents: PE (Petroleum ether bp 60-40 ºC), EtOAc (ethyl acetate), DCM (dichloromethane), THF (tetrahydrofuran) and DMF (dimethylformamide). All products were stored at -20ºC under argon. 2-Hydroxy-5-methoxybenzaldehyde (2) was prepared from 4-methoxyphenol and paraformaldehyde according to the reported method. 16 Numbering of the preussomerins is in accordance with the numbering of the original reference (See Figure 2) . 6H,12H-6,12-Di-(3'-hydroxypropyl)-2,8-dimethoxy-6,12-epoxydibenzo[b,f][1,5]dioxocin 5 and 6H,12H-6-(3'-Hydroxypropyl)-2,8-dimethoxy-6,12-epoxydibenzo[b,f][1,5]dioxocin 6 A solution of bis-acetal 3 (1.72 g, 6.0 mmol) in THF (40 mL) was cooled to -78 ºC under constant pass of a stream of nitrogen and treated with n-BuLi (2.3 M in hexanes, 2.9 mL, 6.7 mmol). The reaction mixture was stirred at -78 ºC for 30 min to provide a deep purple solution. The flask was cooled further to -100 ºC (ethanol/liquid nitrogen mixture) and treated with oxetane (0.4 mL, 6.0 mmol), followed by slow addition of BF 3 ·Et 2 O (830 µL, 6.6 mmol), maintaining the temperature below -90 ºC. The flask was allowed to slowly warm to -40 ºC over 90 min and the resultant orange solution stirred at -40 ºC for a further hour. The mixture was cooled then again to -78 ºC and slowly treated with s-BuLi (1.3 M in hexanes, 6.0 mL, 7.8 mmol) to provide a very dark solution. After stirring at -78 ºC for 30 min, the solution was cooled to -100 ºC and oxetane added (1.2 mL, 18 mmol), followed by slow addition of BF 3 ·Et 2 O (2.4 mL, 19 mmol), maintaining the temperature below -90 ºC. The flask was allowed to warm to -40 ºC over 3 h and the resultant orange solution was stirred at -40 ºC for a further hour. The reaction mixture was quenched by addition of a saturated aqueous solution of NaHCO 3 (50 mL) and ethyl acetate (80 mL). The layers were separated, the organic layer washed with additional saturated NaHCO 3 solution (40 mL) and brine (40 mL) and dried over sodium sulfate. The organic extracts were filtered and the solvent evaporated in vacuo. The crude mixture was purified by flash column chromatography on silica gel (eluting with a polar gradient PE/EtOAc 50 to 90% EtOAc), to provide first the mono-alcohol 6 (0.66 g, 32%), followed by the title compound diol 5 (1.25 g, 52%). Both compounds were isolated as extremely viscous oils and subsequently converted to pale yellow stable foams by repeated evaporation from DCM and high vacuum drying. A pre-cooled (ice bath) solution of Jones' reagent was slowly dropped over an efficiently stirred solution of diol 5 (2.42 g, 6 mmol) in acetone (80 mL) at rt, maintaining a dropping rate such as the temperature does not rise 30 ºC. A green viscous precipitate is formed immediately. When the characteristic red-orange colour of the Jones' reagent persists in the supernatant solution (TLC analysis shows total consumption of the starting material ca. 10 min), the reaction was stirred for additional 5 min at rt, quenched by addition of propan-2-ol (30 mL) and stirred until the precipitate became eventually a finely dispersed suspension (ca. 15 min). The crude product was filtered through a short Celite® pad (sintered glass), washing with acetone and EtOAc. The solvent was removed under reduced pressure and re-dissolved in EtOAc, washed with 10% HCl (2 x 50 mL), brine (50 mL) and dried over MgSO 4 . After filtration and removal of the solvent, the crude diacid was repeatedly evaporated with dichloromethane and finally triturated from PE to form a white amorphous solid of diacid 7 (2.45 g, 95%); R f = 0.4 (EtOAc);  max (film)/cm -1 3000, 2952, 1705, 1497, 1425, 1277, 1225, 1173, 1080, 1037, 933, 879, 818;  H (270 MHz; acetone-d 6 ) 2.4 (2 H, m), 2.71 (2 H, m), 2.47 (4 H, m), 3.73 (6 H, s, 2 x OCH 3 ), 6.75 (2 H, d, J = 9, C2-CH, C2'-CH), 6.83 (2 H, dd, J = 9 and 3, C3-CH, C3'-CH) and 6.98 (2 H, d, J = 3, C5-CH, C5'-CH);  C (125 MHz; acetone-d 6 ) 27.5 (C8, C8'), 32.5 (C9, C9'), 55.0 (2 x OMe), 96.7 (C7, C7'), 109.8 (C2, C2'), 116.9 (C3, C3'), 117.1 (C5, C5'), 122.2 (C6, C6'), 146.0 (C4, C4'), 155.4 (C1, C1') and 173.2 (C10, C10'); m/z (FAB) HRMS Calcd for C 22 
One-pot Friedel-Crafts acylation-desymmetrisation. General procedure
A solution of diacid 7 (0.22 g, 0.5 mmol) in dry dichloromethane (15 mL) was cooled to 0 ºC (ice bath) under nitrogen and treated with DMF (1 drop, catalytic amount), followed by slow addition of oxalyl chloride (0.1 mL, 1.2 mmol). The mixture was warmed to room temperature and stirred for 1 h. Then, the solution was cooled again in an ice bath and diluted with DCM (15 mL), followed by dropwise addition of a freshly prepared solution of aluminium chloride (0.49 g, 3.6 mmoL) in nitromethane (20 mL). The mixture was stirred at room temperature for 20 h and then quenched with 20% w/v aqueous solution of potassium sodium tartrate (50 mL) and stirred for additional 1 h. The mixture was diluted with DCM (15 mL) and extracted. The aqueous layers were diluted with 10% HCl for helping during separation of the layers, and the aqueous phase was washed with additional DCM (2 x 50 mL). The combined organic extracts were dried over sodium sulfate, filtered and solvent evaporated in vacuo. The crude product was loaded onto Celite® and purified by column chromatography on silica gel (eluting with a polar gradient, PE/EtOAc (7:3) to (1:1), (1:6) and finally (0:1)) to provide first the bis-phenolic compound 10 (0.060 g, 33%), followed by 9 (0.083 g, 44%) and finally the dimethoxy compound 8 (0.020 g, 10%). All products were isolated as dark-reddish to pale pink powders after evaporation from cold diethyl ether. (a) 4H,11H-5,6,12,13-Tetrahydro-3,10-dimethoxy-6a,13a-epoxydinaphtho[1,8-bc:1',8'-fg] 
4H,11H-5,6,12,13-Tetrahydro-3-methoxy-6a,13a-epoxydinaphtho[1,8-bc:1',8'-fg] [1,5]dioxocin-4,11-dione 12
(a) A solution of phenol 9 (300 mg, 0.79 mmol) in DCM (6 mL) was cooled to -10 ºC (ice-salt bath) and treated with pyridine (0.60 mL, 7.4 mmol), followed by slow addition of triflic anhydride (0.25 mL, 1.5 mmol). After stirring at room temperature for 4 hours, the reaction mixture was diluted with DCM (20 mL) and washed with saturated NaHCO 3 solution (2 × 10 mL), 10% HCl (2 × 10 mL) and brine (10 mL). The organic extract was dried over Na 2 SO 4 , filtered and the solvent evaporated in vacuo, to provide the crude triflate 11, which was triturated from DCM/EtOAc/PE to afford a white amorphous solid which was used without further purification in the next step; R f = 0.57 (PE/EtOAc (1:6));  H (500 MHz; CDCl 3 ) 2.45 (1 H, ddd, J = 13, 13 and 6.5), 2.50 (1 H, ddd, J = 13, 13 and 6.5), 2.68 (1 H, ddd, J = 13, 6 and 1), 2.73 (1 H, ddd, J = 13, 6 and 1), 2.86 (1 H, ddd, J = 19, 6 and 1), 2.93 (1 H, ddd, J = 19, 6 and 1), 3.18 (1 H, ddd, J = 19, 13 and 6.5), 3.27 (1 H, ddd, J = 19, 13 and 6.5), 3.87 (3H, s), 7.01 (1 H, d, J = 9.2), 7.08 (1 H, d, J = 9.2), 7.1 (1 H, d, J = 9.2) and 7.21 (1 H, d, J = 9.2).
(b) A suspension of the above crude triflate 11 in ethyl acetate/methanol (1:3 v/v, 24 mL) was treated with triethylamine (0.60 mL, 4.3 mmol) at rt. Under nitrogen, Pearlman's catalyst (20% palladium hydroxide on activated charcoal, 100 mg), was added. The flask was then purged with hydrogen and a sequential cycle vacuum-hydrogen was repeated several times. The mixture was stirred at room temperature for 24 h under a hydrogen atmosphere (light overpressure). The black suspension was bubbled with nitrogen and filtered through a short pad of Celite®, washing with ethyl acetate. The filtrate was washed with 10% hydrochloric acid (2 × 10 mL) and brine (10 mL), dried over Na 2 SO 4 and evaporated in vacuo after filtration. The crude product was loaded onto Celite® and purified by flash column chromatography on silica gel (eluting with an PE/EtOAc (1:1) (a) A solution of 12 (345 mg, 1 mmol) in DCM (12 mL) under argon was treated with 2,6-lutidine (390 µL, 3.3 mmol) and TMSOTf (515 µL, 2.8 mmol) and stirred for 15 min at 0 ºC (ice bath) and then 1 h at rt. The reaction was quenched by dilution with DCM (10 mL) and then washed with saturated NaHCO 3 solution (10 mL). The aqueous layers were extracted with DCM (3 x 10 mL) and dried over MgSO 4 , filtered and the solvent evaporated at reduced pressure. The remaining traces of 2,6-lutidine were removed by azeotropic distillation under vacuo with toluene. The brownish oil 14 so generated was dried by azeotropic removal of the water traces with acetonitrile, dried under high vacuum and used without further purification in the next step, R f = 0.67 (PE/EtOAc (7:3));  H (400 MHz; CDCl 3 (b) A solution of the crude bis-silyl enol ether 14 (1 mmol) in dry acetonitrile (12 mL) at rt under argon was treated with Pd(OAc) 2 (470 mg, 2.1 mmol) and stirred for 18 h. After filtration through a short Celite® pad (eluting CHCl 3 ), the crude was purified by column chromatography on silica gel (eluting with a polar gradient PE/EtOAc (7:3) to (1:1) 11H-5,6,12,13-Tetrahydro-3,6,13-trimethoxy-6a,13a-epoxydinaphtho[1,8-bc:1',8'-fg] [1,5]dioxocin-4,11-dione 16 Lithium methoxide (4.4 mg, 0.12 mmol) was added in one portion at rt under argon over a suspension of dienone 15 (7 mg, 0.02 mmol) in dry MeOH (1 mL) and stirred until complete solubilisation of the crude (ca 5 min) and further the beginning of the formation of a white precipitate. After cooling to 0 ºC (ice bath), TBHP (5-6 M solution in decane, 1 mL) was added via microsyringe and the reaction warmed at rt. The original yellow suspension generated a pale brown solution. After 50 min, the reaction was quenched by addition of a saturated solution of sodium sulfite (15 mL) and diluted with EtOAc. The organic phase was separated and washed with brine. The combined aqueous layers were extracted with EtOAc (3 x 50 mL) and the organic extracts were dried over MgSO 4 and filtered. After removal of the solvent, the residue was purified by flash column chromatography on silica gel (eluting with PE/EtOAc (1:1)). Diepoxide 17 was isolated as a viscous oil which was triturated from dichloromethane and excess PE affording a white fine powder (165 mg, 89%); R f 
4H,

Reductive opening of -epoxy ketone 17
(a) NaBH 4 (37 mg, 1 mmol) was added in small portions to a suspension of (PhSe) 2 (152 mg, 0.5 mmol) in absolute ethanol (4 mL) with stirring at room temperature under nitrogen. After vigorous evolution of hydrogen ceased, the colourless faint solution of Na[PhSeB(OEt) 3 ] so generated was cooled to 0 °C (ice bath), and AcOH (67 µL, 1.2 mmol) was added via a microsyringe. The resulting mixture was further stirred for 5 min in the cold and used then without additional treatment. (b) 4H,11H-5,6,12,13-Tetrahydro-3-methoxy-6,13-dihydroxy-6a,13a-epoxydinaphtho[1,8-bc:1',8'-fg] [1,5]dioxocin-4,11-dione 18 A solution of thebis--epoxy ketone 17 (76 mg, 0.2 mmol) in EtOH/AcOH (1:1) v/v (2 mL) was added to the above solution at 0 ºC under nitrogen. The mixture was stirred at 0° C for 10 min and further for 45 min at rt. The reaction mixture was then opened to air for 15 min and diluted with EtOAc. Brine was added and the aqueous layer extracted with EtOAc (3 x 25 mL). The combined organic layers were dried over MgSO 4 and concentrated in vacuo after filtration. The crude residue was washed with 10 mL portions of PE and decanted and further purified by column chromatography on silica gel (using a polar gradient during the elution PE/EtOAc from (1:0) to (1:6)), affording 9-O-methoxy preussomerin L (18) as a pale yellow oil which was converted into a white solid by triturating from PE (51.4 mg, 67%); R f (c) 4H,11H-5,6,12,13-Tetrahydro-3-methoxy-5-oxiran-13-hydroxy-6a,13a-epoxydinaphtho[1,8-bc:1',8'-fg] [1,5]dioxocin-4, 
11-dione 19
The above solution (2 mL, 0.25 mmol) was added to a suspension of bis--epoxy ketone 17 (53 mg, 0.14 mmol) in EtOH/AcOH (1:0.2) v/v (1.2 mL) at rt under argon. After 25 min, the reaction was opened to air for 10 min, diluted with EtOAc (10 mL) and washed with brine. Aqueous layers were extracted with EtOAc (3 x 10 mL) and the combined organic fractions were dried over MgSO 4 , filtered and the solvent eliminated in vacuo. The residue was purified by column chromatography on silica gel (eluting with a polar gradient PE/EtOAc (7:3) to (1:6)), affording the starting material 17 (10 mg, 20%), epoxyalcohol 19 (29 mg, 54%), epoxyalcohol 20 (3.4 mg, 7%) and diol 18 (5.7 mg, 11%), all as yellow waxy solids. The title compound 19 was converted into a white solid by triturating from PE; R f = 0.35 (PE/EtOAc (1:1) 1 H, br s, 3'-OH), 3.04 (1 H, dd, J = 18.6 and 2.7, C2'-CH b ), 3.57 (1 H,  dd, J = 18.6 and 3.4, C2'-CH a ), 3.86 (3 H, s, OCH 3 ), 3.89 (1 H, d, J = 4.3, C3-CH), 4.22 (1 H, d, J = 4.3, C2-CH), 4.80 (1 H, m, C3 '-CH), 7.0 (1 H, d, J = 9.2, C8-CH), 7.07 (1 H, d, J = 9.2, C7-CH), 7.06 (1 H, dd, J = 8.2 and 1, C7'-CH), 7.41 (1 H, dd, J = 8.2 and 7.6, C8'-CH) and 7.67 (1 H, dd, J = 7.6 and 1, C9'-CH);  C (100 MHz; CDCl 3 ) 41.2, 53.0, 53.2, 56.6, 70.1, 94.13, 94.18, 115.93, 115.98,  118.4, 119.1, 120.8, 121.6, 123, 130.8, 131.3, 143.1, 150.2, 153. 11H-5,6,13,13-Tetrahydro-3-methoxy-6-hydroxy-12-oxiran-6a,13a-epoxydinaphtho[1,8-bc:1',8'-fg] [1,5]dioxocin-4,11- 9-I-BBN (1.0 M solution in hexanes, 62 µL, 0.062 mmol) was added dropwise at 0 ºC (ice-bath) under argon to a stirred suspension of the 9-methoxy-protected Preussomerin L (18) (24.8 mg, 0.062 mmol) in dry dichloromethane (5 mL). After 60 min, the reaction was quenched by addition of water (few drops). Stirring was continued and after 5 min, the crude was diluted with dichloromethane and brine and extracted. Aqueous layers were extracted furthermore with dichloromethane. The combined organic fractions were dried over anhydrous MgSO 4 , filtered, concentrated under reduced pressure and the resultant residue purified by column chromatography on silica gel (polar gradient PE/EtOAc = (1:1) to (1:6)) to afford Preussomerin L (9.8 mg, 42%) and recovered starting material 18 (6.6 mg, 27%). Preussomerin L was a pale yellow viscous waxy solid which was converted into an amorphous white solid by solubilisation in dichloromethane followed by addition of PE and triturating. Analytically pure samples were prepared by recrystallisation from methanol affording colourless needles; R f After every addition of the Lewis acid, the reaction vessel was warmed at room temperature for 10 min and monitored by TLC. Once the TLC analysis showed total consumption of the starting material, the reaction was quenched with water (1 mL) and diluted with dichloromethane (10 mL). The aqueous layer was extracted with dichloromethane (3 x 10 mL) and the combined organic layers were dried over MgSO 4 . The solvent was eliminated in vacuo and dried under high vacuum. The crude material was analysed by NMR showing to be a mixture of bromohydrin 21 and preussomerin L in a proportion (8:2). (b) The above crude material was dissolved in absolute ethanol (1 mL) at room temperature under argon. Potasium tert-butoxide was added in one portion. The pale yellow solution turned dark brown immediately. After 45 min, TLC analysis showed complete transformation of the bromohydrin. The reaction was then quenched by addition of a 10% HCl solution (2 mL) and partitioned between water and dichloromethane. Aqueous layer was repeatedly washed with additional dichloromethane and finally the combined organic fractions were dried over MgSO 4. After filtration and evaporation of the solvent, the subsequent residue was purified on silica gel (eluting with PE/EtOAc (1:1)), providing preussomerin L (4.4 mg, 17%), R f = 0.1 (PE/EtOAc (1:1) H, ddd, J = 18.8, 13.2 and 6.3, C2-CH a ), 3.487 (3 H, s, MOM-OCH 3 ), 3.494 (3 H, s, MOM-OCH 3 ), 4.76 (1 H, d, J = 7, CH b -MOM (a) Sodium hexamethyldisilazane (1.0 M solution in THF, 28 µL, 0.028 mmol) was added portionwise via microsirynge to a solution of the protected intermediate 25c (10. 2 mg, 0.023 mmol) in dry THF (2 mL) under argon at -40ºC and stirred for 15 min. The deep orange solution of the enolate so generated was trapped with TMSCl (6 µL, 0.05 mmol) and slowly warmed to -10 ºC, then to 0 ºC and finally to rt over 5 h. Reaction crude was concentrated under reduced pressure and the crude product was efficiently dried under high vacuum, affording a yellow viscous oil which was used without further purification in the next step.
(b) The above crude silyl enol ether was dissolved (solubilisation assisted by sonication) in dry acetonitrile (2 mL) at rt under argon and Pd(OAc) 2 (6.2 mg, 0.028 mmol) was added in one portion. The reaction was stirred for 15 h. After filtration through a short Celite® pad (EtOAc washings), the solvent was eliminated and the residue purified by column chromatography on silica gel (eluting PE/EtOAc (7:3)), affording the hydrolysed starting material 25c (2.5 mg, 25%) and the title enone 26c (7.6 mg, 75%) as a waxy viscous solid; R f TBD (1 mg, 0.006 mmol) was added to a solution of the enone 26c (9.4 mg, 0.02 mmol) in dry toluene (1.2 mL) under argon at rt. After cooling at 0 ºC (ice bath), TBHP (5-6 M solution in decane, 24 µL) was added via microsyringe and the reaction warmed to rt. The original yellow solution turned off in a colourless solution. After 40 min, the reaction was quenched by addition of a saturated solution of sodium sulfite (2 mL) and diluted with EtOAc. The organic phase was separated and washed with brine. The combined aqueous layers were extracted with EtOAc (3 x 10 mL) and the combined organic extracts dried over MgSO 4 and filtered. After removal of the solvent, the residue was purified by flash column chromatography on silica gel (eluting with PE/EtOAc (7:3)). Epoxide 27c was isolated as a colourless wax (8. A dilute solution of HCl in isopropyl alcohol was prepared prior to use by dropping concentrated HCl (3 drops, ca 60 µL) in isopropyl alcohol (10 mL). The MOM-protected epoxyketone 27c (4.8 mg, 0.01 mmol) was dissolved in 2 mL of this freshly prepared solution and heated at 50 ºC for 8 h under argon. The reaction was quenched by addition of solid NaHCO 3 , diluted with EtOAc and filtered through a short cotton pad, washing with additional EtOAc. The solvent was eliminated and the residue purified further by column chromatography on silica gel (eluting PE/EtOAc polar gradient (7:3) to (1:1)) affording the desired deprotected title compound Preussomerin F (2.4 mg, 66%) and diol 29 (1.3 mg, 34%) as waxy solids; Preussomerin F, R f = 0.32 (PE/EtOAc (1:1));  max (film)/cm 
